Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Gross Profit (2016 - 2025)

Medifast (MED) has disclosed Gross Profit for 16 consecutive years, with $52.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit fell 40.9% year-over-year to $52.1 million, compared with a TTM value of $275.2 million through Dec 2025, down 38.11%, and an annual FY2025 reading of $275.2 million, down 38.11% over the prior year.
  • Gross Profit was $52.1 million for Q4 2025 at Medifast, down from $62.2 million in the prior quarter.
  • Across five years, Gross Profit topped out at $321.7 million in Q2 2022 and bottomed at $52.1 million in Q4 2025.
  • Average Gross Profit over 5 years is $188.2 million, with a median of $194.0 million recorded in 2023.
  • The sharpest move saw Gross Profit soared 84.37% in 2021, then plummeted 48.34% in 2024.
  • Year by year, Gross Profit stood at $278.3 million in 2021, then fell by 16.06% to $233.6 million in 2022, then plummeted by 39.48% to $141.4 million in 2023, then tumbled by 37.6% to $88.2 million in 2024, then crashed by 40.9% to $52.1 million in 2025.
  • Business Quant data shows Gross Profit for MED at $52.1 million in Q4 2025, $62.2 million in Q3 2025, and $76.6 million in Q2 2025.